Received: 8 November 2020
Accepted: 5 February 2021
First Online: 19 February 2021
Ethics approval and consent to participate
: The study was conducted according to the Declaration of Helsinki and approved by the Danish Health Research Ethics Committee (file number 20110022). Patients were enrolled after written informed consent from a legal next of kin and the patient’s general practitioner.
: Not applicable.
: AMG declares to have received speaking fee from Novartis and Merck Sharp and Dome (MSD). All other authors declare no conflicts of interest.